Given the task definition, example input & output, solve the new input case.
In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.
Example: SECTION 1. LIABILITY OF BUSINESS ENTITIES PROVIDING USE OF FACILITIES
TO NONPROFIT ORGANIZATIONS.

(a) Definitions.--In this section:
(1) Business entity.--The term ''business entity'' means a
firm, corporation, association, partnership, consortium, joint
venture, or other form of enterprise.
(2) Facility.--The term ''facility'' means any real
property, including any building, improvement, or appurtenance.
(3) Gross negligence.--The term ''gross negligence'' means
voluntary and conscious conduct by a person with knowledge (at
the time of the conduct) that the conduct is likely to be
harmful to the health or well-being of another person.
(4) Intentional misconduct.--The term ''intentional
misconduct'' means conduct by a person with knowledge (at the
time of the conduct) that the conduct is harmful to the health
or well-being of another person.
(5) Nonprofit organization.--The term ''nonprofit
organization'' means--
(A) any organization described in section 501(c)(3)
of the Internal Revenue Code of 1986 and exempt from
tax under section 501(a) of such Code; or
(B) any not-for-profit organization organized and
conducted for public benefit and operated primarily for
charitable, civic, educational, religious, welfare, or
health purposes.
(6) State.--The term ''State'' means each of the several
States, the District of Columbia, the Commonwealth of Puerto
Rico, the Virgin Islands, Guam, American Samoa, the Northern
Mariana Islands, any other territory or possession of the
United States, or any political subdivision of any such State,
territory, or possession.
(b) Limitation on Liability.--
(1) In general.--Subject to subsection (c), a business
entity shall not be subject to civil liability relating to any
injury or death occurring at a facility of the business entity
in connection with a use of such facility by a nonprofit
organization if--
(A) the use occurs outside of the scope of business
of the business entity;
(B) such injury or death occurs during a period
that such facility is used by the nonprofit
organization; and
(C) the business entity authorized the use of such
facility by the nonprofit organization.
(2) Application.--This subsection shall apply--
(A) with respect to civil liability under Federal
and State law; and
(B) regardless of whether a nonprofit organization
pays for the use of a facility.
(c) Exception for Liability.--Subsection (b) shall not apply to an
injury or death that results from an act or omission of a business
entity that constitutes gross negligence or intentional misconduct,
including any misconduct that--
(1) constitutes a crime of violence (as that term is
defined in section 16 of title 18, United States Code) or act
of international terrorism (as that term is defined in section
2331 of title 18) for which the defendant has been convicted in
any court;
(2) constitutes a hate crime (as that term is used in the
Hate Crime Statistics Act (28 U.S.C. 534 note));
(3) involves a sexual offense, as defined by applicable
State law, for which the defendant has been convicted in any
court; or
(4) involves misconduct for which the defendant has been
found to have violated a Federal or State civil rights law.
(d) Superseding Provision.--
(1) In general.--Subject to paragraph (2) and subsection
(e), this Act preempts the laws of any State to the extent that
such laws are inconsistent with this Act, except that this Act
shall not preempt any State law that provides additional
protection from liability for a business entity for an injury
or death with respect to which conditions under subparagraphs
(A) through (C) of subsection (b)(1) apply.
(2) Limitation.--Nothing in this Act shall be construed to
supersede any Federal or State health or safety law.
(e) Election of State Regarding Nonapplicability.--This Act shall
not apply to any civil action in a State court against a business
entity in which all parties are citizens of the State if such State
enacts a statute--
(1) citing the authority of this subsection;
(2) declaring the election of such State that this Act
shall not apply to such civil action in the State; and
(3) containing no other provision.
Output: Shields a business entity from civil liability relating to any injury or death occurring at a facility of that entity in connection with a use of such facility by a nonprofit organization if: (1) the use occurs outside the scope of business of the business entity; (2) such injury or death occurs during a period that such facility is used by such organization; and (3) the business entity authorized the use of such facility by the organization.
Makes this Act inapplicable to an injury or death that results from an act or omission of a business entity that constitutes gross negligence or intentional misconduct, including misconduct that: (1) constitutes a hate crime or a crime of violence or act of international terrorism for which the defendant has been convicted in any court; or (2) involves a sexual offense for which the defendant has been convicted in any court or misconduct for which the defendant has been found to have violated a Federal or State civil rights law.
Preempts State laws to the extent that such laws are inconsistent with this Act, except State law that provides additional protection from liability. Specifies that this Act shall not be construed to supersede any Federal or State health or safety law.
Makes this Act inapplicable to any civil action in a State court against a business entity in which all parties are citizens of the State if such State, citing this Act's authority and containing no other provision, enacts a statute declaring the State's election that this Act shall not apply to such action in the State.
This Bill focuses on shielding business entities from civil liability relating to an injury or death depending on the conditions of injury, hence the generated summary is correct.

New input case for you: SECTION 1. SHORT TITLE.

This Act may be cited as the ''Eliminating Disparities in Breast
Cancer Treatment Act of 2008''.

SEC. 2. FINDINGS.

Congress finds the following:
(1) Delays in receiving care after breast cancer diagnosis
are reported to be greater for African-American women than
white women.
(2) Recent studies indicate that African-American women
with breast cancer are less likely to receive standard therapy
than white women.
(3) African-American and Hispanic patients are
significantly more likely than white patients to be diagnosed
at a more advanced stage of breast cancer.
(4) Investigators found that regardless of insurance
status, African-American women are 1.9 times more likely to be
diagnosed with an advanced stage of breast cancer than white
women and Hispanic women are 1.4 times more likely to be
diagnosed with an advanced stage of breast cancer than white
women.
(5) African-American women are ten percent more likely not
to receive tests to determine if breast cancer has spread to
axillary (underarm) lymph nodes. Studies show that health
insurance status, race, income, and educational background are
directly linked to irregularity in administering this vital
screening.
(6) According to American Cancer Society researchers,
substantial disparities remain or persist regarding cancer
diagnosis and treatment.

SEC. 3. PURPOSE.

The purpose of this Act is to promote the implementation of
standardized health care practices for breast cancer treatment under
the Medicare program to eliminate disparities in the provision of care
to such patients based on race, level of education, income, and health
insurance status of such patients.

SEC. 4. CONSENSUS-BASED BREAST CANCER TREATMENT PERFORMANCE MEASURES
SYSTEM UNDER MEDICARE.

Title XVIII of the Social Security Act is amended by adding at the
end the following new section:

''SEC. 1898. BREAST CANCER TREATMENT PERFORMANCE MEASURES SYSTEM.

''(a) In General.--Not later than October 1, 2009, the Secretary
shall establish, in accordance with the provisions of this section, a
6-year breast cancer treatment quality performance system (in this
section referred to as the 'system') to--
''(1) assess and publicly disclose, through the use of
quality measures, the quality of care provided for the
treatment of breast cancer by specified health care providers;
and
''(2) beginning October 1, 2012, base payment under this
title to such providers for such treatment on the performance
of such providers based on such measures.
''(b) Specified Health Care Providers.--
''(1) In general.--The Secretary shall specify classes of
providers of services and suppliers, including hospitals,
cancer centers, physicians, primary care providers, and
specialty providers, to which the provisions of this section
shall apply.
''(2) Definition.--For purposes of this section, the term
'specified health care provider' means a provider of services
or supplier specified under paragraph (1).
''(c) Identification and Endorsement of Breast Cancer Treatment
Performance Measures.--
''(1) In general.--Under the system, the Secretary, shall
enter into agreements with the National Quality Forum, an
organization that operates as a voluntary consensus standards
body as defined for purposes of section 12(d) of the National
Technology Transfer and Advancement Act of 1995 (Public Law
104-113) and Office of Management and Budget Revised Circular
A-119 (published in the Federal Register on February 10, 1998),
under which the National Quality Forum shall identify a uniform
set of consensus-based performance measures to evaluate the
quality of care provided by specified health care providers for
the treatment of breast cancer, endorse such set of measures
through its multistakeholder consensus development process, and
annually update such set of measures.
''(2) Measures described.--The set of measures described in
paragraph (1) shall include, with respect to the treatment of
breast cancer, measures of patient outcomes, the process for
delivering medical care related to such treatment, patient
counseling and engagement in decision-making, patient
experience of care, resource use, and practice capabilities,
such as care coordination.
''(d) Reporting Process.--
''(1) In general.--Under the system, for periods (as
specified by the Secretary) beginning on or after October 1,
2009, the Secretary shall establish a reporting process, with
respect to treatment furnished for breast cancer, that provides
for a method for specified health care providers to submit to
the Secretary data on the performance of such providers during
each period through use of the performance measures developed
pursuant to subsection (c)(1). Such data shall be submitted in
a form and manner and at a time specified by the Secretary.
''(2) Voluntary submission during initial 3 years.--The
reporting process under paragraph (1) shall provide for the
voluntary submission of data (and incentives for such
submission) under the process for periods ending before October
1, 2012.
''(3) Characteristics of data submitted under reporting
process.--Data submitted by a specified health care provider
under the reporting process under paragraph (1) shall--
''(A) take into account the quality of breast
cancer treatment furnished to all patients of the
provider, regardless of the type of health insurance
coverage of the patient or whether or not the patient
has such coverage; and
''(B) be structured in a manner that allows for
comparison according to race, educational level,
income, insurance status, and any other category
specified by the Secretary.
''(e) Public Disclosure.--Under the system, the Secretary shall
establish procedures to require that information with respect to the
quality demonstrated by a specified health care provider of treatment
furnished for breast cancer during a period (based on the performance
measures data submitted pursuant to subsection (c)(1) by the provider
for such period) is made available on the official public Internet site
of the Department of Health and Human Services in a clear and
understandable form. Such procedures shall ensure that a specified
health care provider has the opportunity to review the information that
is to be made public with respect to the provider at least 30 days
prior to such data being made public and shall provide for an appeals
process in the case a provider claims such information to be incorrect
or incomplete.
''(f) Value-Based Purchasing for Periods Beginning October 1,
2012.--
''(1) In general.--Under the system, for periods beginning
on or after October 1, 2012 and ending before October 1, 2015,
the Secretary shall establish and implement, a value-based
purchasing program, with respect to specified health care
providers that furnish treatment for breast cancer during such
a period, under which--
''(A) in the case of such a provider that does not
submit data in accordance with the reporting process
under subsection (d)(1) for such treatment furnished
during such period, the Secretary shall reduce payment
under this title for such treatment by an amount
specified by the Secretary; and
''(B) in the case of such a provider that submits
data in accordance with the reporting process under
subsection (d)(1) for such treatment furnished during
such period--
''(i) subject to clause (ii), if the
Secretary determines such provider furnished
low quality care (in accordance with a method
specified by the Secretary) for such treatment,
the Secretary shall reduce the amount that
would otherwise be paid to such provider under
this title for such treatment by an amount
specified by the Secretary;
''(ii) if the Secretary determines such
provider furnished low quality care (in
accordance with the method specified under
clause (i)) for such treatment, but the quality
of care has improved as compared to the quality
of care the provider furnished during the
previous period, the Secretary shall reduce the
amount that would otherwise be paid to such
provider under this title for such treatment in
accordance with an incremental method
established by the Secretary that ensures that
the amount of such reduction--
''(I) is less than the amount
specified by the Secretary under clause
(i); and
''(II) is based on the extent of
improvement in the quality of care; and
''(iii) if the Secretary determines such
provider did not furnish low quality care (in
accordance with the method specified under
clause (i)) for such treatment, the Secretary
shall provide to such provider the amount to be
paid to such provider under this title for such
treatment.
''(2) Results-based payments.--The amount of a reduction
under subparagraph (A) or (B)(i) of paragraph (1) shall be
determined in accordance with a method established by the
Secretary.
''(g) Reports.--Not later than October 1, 2010, and for each 6-
month period thereafter (before fiscal year 2016), the Secretary shall
submit to Congress a report that evaluates the development and
implementation of the system, including--
''(1) an evaluation of the number of specified health care
providers that submit data pursuant to subsection (c)(1);
''(2) an analysis of the effect of such system on reducing
disparities in the provision of breast cancer treatment to
patients based on race, level of education, income, and health
insurance status of such patients;
''(3) recommendations on whether (and to what extent) to
extend the system under this section.
''(h) Application to Part C.--The Secretary shall provide for a
method to apply the provisions of this section to treatment furnished
under a plan under part C.''.
Output:
Eliminating Disparities in Breast Cancer Treatment Act of 2008 - Amends title XVIII (Medicare) of the Social Security Act to direct the Secretary of Health and Human Services to establish a breast cancer treatment quality performance system to: (1) assess and disclose publicly, through the use of quality measures, the quality of care provided for the treatment of breast cancer by specified health care providers; and (2) base payment to such providers for such treatment on their performance with respect to such measures.

Requires reduced payments to providers that either do not submit data in accordance with the reporting process in the system, or furnish low quality care for treatment of breast cancer.